A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer
NCT04928625
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Pancreatic Cancer
Interventions
DRUG:
SHR-A1904
Sponsor
Shanghai Hengrui Pharmaceutical Co., Ltd.